Nelson Benjers
Clinton, MDNPI 1629069968
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,862 of the $8,536 with a category attached, or 80.4%. It is spread thinly across 28 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,946 and has fallen 87.5% since, to $368 in 2025.
Across 246 payments — averaging $34.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- AstraZeneca$733
- Amgen$619
- Pfizer$525
- Johnson & Johnson$504
- Abbott$477
- plus $4K from 22 others
What the payments were for
- Travel & lodging$1,54418%
- Food & beverage$6,86280%
- Education$1302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 12 | $1,963 |
| AstraZeneca | 25 | $733 |
| Amgen | 25 | $619 |
| Pfizer | 26 | $525 |
| Johnson & Johnson | 21 | $504 |
| Abbott | 7 | $477 |
| Esperion Therapeutics, Inc. | 11 | $467 |
| Actelion Pharmaceuticals US, Inc. | 10 | $323 |
| Boehringer Ingelheim | 10 | $310 |
| E.r. Squibb & Sons, L.L.C. | 11 | $292 |
| Sanofi-aventis U.S. LLC | 7 | $273 |
| Novo Nordisk | 14 | $271 |
| Novartis | 14 | $256 |
| GSK | 5 | $198 |
| Merck | 11 | $193 |
| Lilly USA, LLC | 5 | $182 |
| Bridgebio Pharma, Inc. | 1 | $142 |
| Boston Scientific | 1 | $125 |
| Arbor Pharmaceuticals, Inc. | 6 | $113 |
| Cvrx, Inc. | 1 | $100 |
| Kowa Pharmaceuticals America, Inc. | 7 | $99 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $93 |
| Vanda Pharmaceuticals Inc. | 5 | $91 |
| Philips North America LLC | 3 | $64 |
| Medtronic | 1 | $53 |
| Lexicon Pharmaceuticals, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY ABLATION SYSTEM$907
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$877
- NEXLIZET$247
- NEXLETOL$247
- PRALUENT$180
- FreeStyle Lite system$148
- Attruby$142
- LOKELMA$126
- Watchman$125
- TRELEGY ELLIPTA$125
- UPTRAVI$125
- OPSUMIT$125
- JARDIANCE$122
- FARXIGA$118
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.